Bioventus Inc
NASDAQ:BVS
Bioventus Inc
Net Income (Common)
Bioventus Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
B
|
Bioventus Inc
NASDAQ:BVS
|
Net Income (Common)
-$158.7m
|
CAGR 3-Years
-510%
|
CAGR 5-Years
-85%
|
CAGR 10-Years
N/A
|
Cooper Companies Inc
NYSE:COO
|
Net Income (Common)
$290.8m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Net Income (Common)
-$132m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Align Technology Inc
NASDAQ:ALGN
|
Net Income (Common)
$462.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
13%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Net Income (Common)
$326.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
See Also
What is Bioventus Inc's Net Income (Common)?
Net Income (Common)
-158.7m
USD
Based on the financial report for Dec 31, 2022, Bioventus Inc's Net Income (Common) amounts to -158.7m USD.
What is Bioventus Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-85%
The average annual Net Income (Common) growth rates for Bioventus Inc have been -510% over the past three years , -85% over the past five years .